The promise of psychedelic medicine in psychiatry.
Nat Med November 1, 2025 DOI: 10.1038/d41591-025-00062-4 via PubMed
Summary
AI-generated from the abstractPsychedelic medicine holds promise for treating a range of psychiatric conditions, particularly depression and post-traumatic stress disorder, by inducing profound changes in consciousness and brain function. The article discusses the potential of substances like psilocybin and MDMA to facilitate therapeutic breakthroughs when combined with psychotherapy. It highlights that these treatments may offer lasting benefits after only a few sessions, though challenges remain regarding safety, accessibility, and integration into mainstream clinical practice. The authors suggest that careful research and regulation could unlock significant advances in mental health care.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Key finding | Psychedelic medicine shows promise for treating psychiatric conditions like depression and PTSD, but challenges in safety and integration remain. |
Abstract
The promise of psychedelic medicine in psychiatry.